Clinical outcome studies have shown that it is safe to withhold anticoagulant therapy in patients
with suspected pulmonary embolism (PE) who have a negative D-dimer result and a low …

Background: Case-fatality rates are important for assessing the risks and benefits of
anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize case-…

Background:Pretest probability assessment is necessary to identify patients in whom
pulmonary embolism (PE) can be safely ruled out by a negative D-dimer without further …

Background: Diagnosis of pulmonary embolism requires clinical probability assessment.
Implicit assessment is accurate but is not standardized, and current prediction rules have …

Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …

Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …

Objectives : This trial sought to assess the influence of omeprazole on clopidogrel efficacy.
Background : Clopidogrel has proved its benefit in the treatment of atherothrombotic diseases…

The presence of a clot – even asymptomatic – in the proximal lower limb veins of a patient
with clinically suspected pulmonary embolism (PE) provides evidence for venous …

Importance D-dimer measurement is an important step in the diagnostic strategy of clinically
suspected acute pulmonary embolism (PE), but its clinical usefulness is limited in elderly …

Background Single-detector–row computed tomography (CT) has a low sensitivity for
pulmonary embolism and must be combined with venous-compression ultrasonography of the …